Increase in Electrodermal Activity on Acupuncture Points of Lymphatic, Lung, Nervous, Endocrine and Heart Meridians after Running Exercise, a Single Case Study

Hong, Harry G.

doi:10.21926/obm.icm.1901019

Cited by 2 publications

(1 citation statement)

References 19 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies on electrodermal measurement of acupoints have shown a relationship between changes in acupuncture point electrical impedance and several clinical conditions and that experimentally induced physiological stress and subsequent recovery correlate with changes in acupuncture point electrical activity [18,19].Electrodermal impedance measurement was used to screen various conditions, including cystic fibrosis, chronic pelvic pain, lung cancer, gastrointestinal bleeding, and assessment of a person's emotional state [20][21][22][23][24][25]. The correlation between changes in the electrodermal activity of APs and respiratory conditions and the electrodermal activity of APs of different meridians of the EAV diagnosis with running exercise has been demonstrated [10,26]. The results of a non-invasive MT method for determining the daily doses of sofosbuvir in patients with chronic hepatitis C infection are described [8].…”

Section: Discussionmentioning

confidence: 99%

Medicament Testing in the Diagnosis of Long COVID Syndrome

Djumaeva,

Akhundjanova,

Djumaeva

et al. 2024

OBM Integr Complement Med

View full text Add to dashboard Cite

Long COVID syndrome resulting from SARS-CoV-2 infection has a prevalence of 10%-35% in the population. Numerous studies of the disease are currently being conducted concerning the manifestations of long COVID syndrome; however, there are no data on the use of electroacupuncture diagnosis (EAV) and medicament testing (MT) in assessing this condition. The purpose of the study was to study the possibilities of diagnosing EAV to determine changes in the electrodermal activity of acupuncture points of the meridian test system - EAV in patients with long COVID syndrome, as well as to identify drugs that can influence the altered electrodermal impedance at these acupuncture points based on the results of MT. At present, the physiological basis of this phenomenon is still unknown.<strong> </strong>This blind, randomized, placebo-controlled trial included 89 patients (aged from 16 to 50) with long COVID syndrome, who were examined with EAV based on measuring the electrodermal impedance of acupuncture points (APs), followed by testing the RNA polymerase nosode, ribavirin, and dexamethasone at those acupuncture points where a decrease in electrodermal activity was recorded. A reduction of electrodermal activity was observed in APs of various meridians of Voll diagnosis, with this phenomenon being more pronounced in the Nervous Degeneration and Circulation (Voll). The use of RNA polymerase nosode, ribavirin (tablets), and dexamethasone (pills) in the process of MT with positive reaction to testing drugs in specified APs with decreased levels of electrodermal activity in some patients has led to the normalization of indexes of electrodermal impedance in the studied APs. The results of the research suggested the feasibility of using EAV diagnostics to identify the APs of meridians with a decreased level of electrodermal activity, followed by MT using an RNA polymerase nosode, ribavirin, and dexamethasone as drugs, that contribute to the restoration of electrodermal impedance at the APs of the identified meridians in some patients with long COVID syndrome. Further clinical and instrumental studies are needed to evaluate the clinical application of medication testing in assessing long COVID syndrome further.

show abstract

Section: Discussionmentioning

confidence: 99%

Medicament Testing in the Diagnosis of Long COVID Syndrome

Djumaeva,

Akhundjanova,

Djumaeva

et al. 2024

OBM Integr Complement Med

View full text Add to dashboard Cite

show abstract

Ribavirin’s Daily Dose Growth Determined as the Result of Medicament Testing May Be a Predictor of the Chronic Course of the Disease in Long COVID Syndrome Patients

Djumaeva,

Akhunjanova

et al. 2024

Preprint

View full text Add to dashboard Cite

Introduction Long COVID syndrome, a multisystemic condition resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, affects at least 65 million people worldwide. The disease pathogenesis is unclear, and many different assumptions still exist. This study aimed to explore the use of medicament testing to determine the optimal daily dose of ribavirin through the use of electroacupuncture via the Voll (EAV) diagnostic system for acupuncture points. Materials and methods One hundred one patients (aged 16 to 50) with long COVID syndrome were recruited from the Research Institute of Virology and were eligible according to the inclusion criteria. Patients were randomized to the experimental or the placebo groups. The patients were further examined with EAV diagnostics based on the level of electrodermal activity at the acupuncture points, followed by medicament testing with ribavirin (tablets) to determine the daily doses of the drug. Fifty-two participants were randomized to the experimental group and fourty nine to the placebo group and were considered for data analyses. Results The results of this study demonstrated the feasibility of using EAV to identify meridians with decreased levels of electrodermal activity at acupuncture points, followed by medicament testing with ribavirin to restore the decreased electrodermal conductivity at the studied acupuncture points and to measure the daily dose of the drug. Conclusions The measured daily doses of ribavirin in patients with long COVID syndrome may indirectly serve as a prognostic marker of the course of the disease. However, further clinical and instrumental studies are needed to evaluate the clinical application of medicament testing in assessing long-term COVID syndrome.

show abstract

Increase in Electrodermal Activity on Acupuncture Points of Lymphatic, Lung, Nervous, Endocrine and Heart Meridians after Running Exercise, a Single Case Study

Cited by 2 publications

References 19 publications

Medicament Testing in the Diagnosis of Long COVID Syndrome

Medicament Testing in the Diagnosis of Long COVID Syndrome

Ribavirin’s Daily Dose Growth Determined as the Result of Medicament Testing May Be a Predictor of the Chronic Course of the Disease in Long COVID Syndrome Patients

Contact Info

Product

Resources

About